"10.1371_journal.pone.0110086","plos one","2014-11-07T00:00:00Z","Jin A Cho; Xuan Zhang; Gregory M Miller; Wayne I Lencer; Flavia C Nery","Division of Gastroenterology/Cell Biology, Boston Childrens Hospital, Harvard Medical School, Boston, MA, United States of America; Neuroscience Center, Department of Neurology, and Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Boston, MA, United States of America; Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA, United States of America; Harvard Digestive Diseases Center, Harvard Medical School, Boston, MA, United States of America","Conceived and designed the experiments: FCN JAC GMM WIL. Performed the experiments: FCN JAC XZ. Analyzed the data: FCN JAC XZ. Contributed reagents/materials/analysis tools: FCN JAC WIL. Wrote the paper: FCN JAC GMM WIL.","Authors J.A.C., W.I.L., and F.C.N. have applied for a patent for the use of drug 4-PBA in the treatment of movement disorders, including dystonia. There are no other patents, products in development or marketed products to declare. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","11","Jin A Cho","JAC",5,TRUE,4,3,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
